What should we investigate next?
Start with the decision, then open the evidence. Every lead keeps pathway, premises and economics as independent gates.
Move the right opportunities forward
Counts may overlap because legal pathway, site evidence and economics are separate questions.
Strongest decisions to examine now
Turn opportunity signals into accountable work
Move each site from signal to decision
Assign the work, verify every evidence gap and preserve the decision history without changing the underlying GapMaps release.
Evidence boundary: assignments, notes and verification outcomes are user-entered workflow records. They never overwrite or silently strengthen the GapMaps-supplied facts, Location Rules screen or assumption-dependent economics.
Know exactly what every result means
The dashboard publishes one canonical opportunity release and labels observed, derived and assumed evidence separately.
Where the strongest pathways are concentrated
Explore the GapMaps-only screen by state, rule pathway and nearby pharmacy competition.
Opportunity overview
Screening-positive sites by state
State chart data is loading.
Positive screening pathways
Rule-pathway chart data is loading.
GapMaps pharmacy competition
Competition chart data is loading.
Ten strongest screened opportunities
| # | Name | State | Rule | Score | Confidence |
|---|
Source coverage and freshness
Opportunity density layer
Toggle GapMaps anchor density around positively screened sites. No population estimate is applied.
Largest pharmacy gaps
Near-misses worth investigating
GapMaps-only sites that came closest to a numeric rule threshold. This is an evidence-closeness screen, not a prediction of ministerial approval and not legal advice. It uses available data only; no public-interest, hardship or statutory-discretion assessment has been made. .
Screen sites worth verifying
Prioritise plausible regulatory pathways, premises leads and downside-tested modelled economics. Every geographic demand signal comes from the supplied GapMaps extraction; every financial assumption is visible and replaceable.
Promising and conditional new-pharmacy leads come first. Each states the potential item, positive signals, obstacles and next evidence check. Potential does not mean approval.
Ranked new-pharmacy leads
Potential ranks by evidence band and score, then premises availability. Positive-rule and Ministerial queues retain their demand-first ranking. Every potential item needs application-grade proof.GapMaps-supplied commercial records—including integrated third-party provider feeds—and economic outputs are screening evidence only. A listing may have changed; pharmacy use may be prohibited; demand uses an SA2-area and geodesic-distance screen; and no location is approved or investable until the rules, premises, rent, staffing and trading assumptions are independently established.